A current problem in modern medicine is the development of drug resistance mutations.This occurs when a mutation arises in a disease-causing microbe making it resistant to a drug and thus rendering the drug useless in treating a specific disease.Many useful drugs are competitive inhibitors of specific enzymes, and the drug-resistance mutations prevent the binding of the drug.These types of mutations, in addition to preventing competitive inhibitor binding, can also sometimes reduce the activity of the enzyme.Why is that the case? rev: 01_20_2015_QC_CS-4567
A) Binding to the competitive inhibitor is essential for the function of the enzyme
B) These mutations most likely affect an allosteric site on the enzyme
C) These mutations lower the activation energy of the reaction catalyzed by the enzyme
D) These mutations most likely change the shape of the active site of the enzyme
Correct Answer:
Verified
Q23: Tacrolimus (FK-506)is a drug that inhibits an
Q26: Glucose is converted into glucose 6-phosphate by
Q27: A new antibiotic has been developed that
Q28: You are studying an enzyme-catalyzed reaction that
Q28: You are working with a specific enzyme-catalyzed
Q33: Does ADP contain the capacity to provide
Q34: A new antibiotic has been developed.It acts
Q38: The Law of Thermodynamics that states that
Q39: Under standard conditions,ATP can release for every
Q40: In order to reuse an enzyme after
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents